Diabetes mutations delineate an atypical POU domain in HNF-1α

Molecular Cell

Volumn 10, Issue 5, 2002, Pages 1129-1137

  Chi, Young In ^a   Frantz, J Daniel ^a,b   Oh, Byung Chul ^a   Hansen, Lone ^a   Dhe Paganon, Sirano ^a   Shoelson, Steven E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; NUCLEAR FACTOR I; NUCLEAR FACTOR IALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CRYSTALLIZATION; DIABETES MELLITUS; MUTATION; PREDICTION; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE DATABASE;

EID: 0036862511     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00704-9     Document Type: Article

References (52)

1. Bjorkhaug L., Ye H., Horikawa Y., Sovik O., Molven A., Njolstad P.R. MODY associated with two novel hepatocyte nuclear factor-1alpha loss-of-function mutations (P112L and Q466X). Biochem. Biophys. Res. Commun. 279:2000;792-798.
2. Boulikas T. Putative nuclear localization signals (NLS) in protein transcription factors. J. Cell. Biochem. 55:1994;32-58.
3. Brunger A.T., Adams P.D., Clore G.M., Delano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.-S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography and NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921.
4. Ceska T.A., Lamers M., Monaci P., Nicosia A., Cortese R., Suck D. The X-ray structure of an atypical homeodomain present in the rat liver transcription factor LFB1/HNF1 and implications for DNA binding. EMBO J. 12:1993;1805-1810.
5. Chevre J.C., Hani E.H., Boutin P., Vaxillaire M., Blanche H., Vionnet N., Pardini V.C., Timsit J., Larger E., Charpentier G.et al. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia. 41:1998;1017-1023.
6. CCP4 Collaborative Computational Project 4) The CCP4 suite. programs for protein crystallography Acta Crystallography D. 50:1994;760-776.
7. Courtois G., Morgan J.G., Campbell L.A., Fourel G., Crabtree G.R. Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters. Science. 238:1987;688-692.
8. D'Elia A.V., Tell G., Paron I., Pellizzari L., Lonigro R., Damante G. Missense mutations of human homeoboxes. A review Hum. Mutat. 18:2001;361-374.
9. Duncan S.A., Navas M.A., Dufort D., Rossant J., Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science. 281:1998;692-695.
10. Ellard S. Hepatocyte nuclear factor 1 alpha (HNF-1 α) mutations in maturity-onset diabetes of the young. Hum. Mutat. 16:2000;377-385.
11. Emens L.A., Landers D.W., Moss L.G. Hepatocyte nuclear factor 1α is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. Proc. Natl. Acad. Sci. USA. 89:1992;7300-7304.
12. Fajans S.S., Bell G.I., Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345:2001;971-980.
13. Frayling T.M., Bulamn M.P., Ellard S., Appleton M., Dronsfield M.J., Mackie A.D., Baird J.D., Kaisaki P.J., Yamagata K., Bell G.I.et al. Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the UK. Diabetes. 46:1997;720-725.
14. Froguel P., Velho G. Genetic determinants of type 2 diabetes. Recent Prog. Horm. Res. 56:2001;91-105.
15. Glucksmann M.A., Lehto M., Tayber O., Scotti S., Berkemeier L., Pulido J.C., Wu Y., Nir W.J., Fang L., Markel P.et al. Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes. 46:1997;1081-1086.
16. Hansen T., Eiberg H., Rouard M., Vaxillaire M., Moller A.M., Rasmussen S.K., Fridberg M., Urhammer S.A., Holst J.J., Almind K.et al. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene. evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation Diabetes. 46:1997;726-730.
17. Hattersley A.T. Maturity-onset diabetes of the young. clinical heterogeneity explained by genetic heterogeneity Diabet. Med. 15:1998;15-24.
18. Hegele R.A., Hanley A.J., Zinman B., Harris S.B., Anderson C.M. Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care. 22:1999;2095-2096.
19. Hua Q.X., Zhao M., Narayana N., Nakagawa S.H., Jia W., Weiss M.A. Diabetes-associated mutations in a beta-cell transcription factor destabilize an antiparallel "mini-zipper" in a dimerization interface. Proc. Natl. Acad. Sci. USA. 97:2000;1999-2004.
20. Iwasaki N., Oda N., Ogata M., Hara M., Hinokio Y., Oda Y., Yamagata K., Kanematsu S., Ohgawara H., Omori Y.et al. Mutations in the hepatocyte nuclear factor-1alpha/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes. 46:1997;1504-1508.
21. Jacobson E.M., Li P., Leon-del-Rio A., Rosenfeld M.G., Aggarwal A.K. Structure of Pit-1 POU domain bound to DNA as a dimer. unexpected arrangement and flexibility Genes Dev. 11:1997;198-212.
22. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119.
23. Kaisaki P.J., Menzel S., Lindner T., Oda N., Rjasanowski I., Sahm J., Meincke G., Schulze J., Schmechel H., Petzold C.et al. Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM. evidence for a mutational hotspot in exon 4 Diabetes. 46:1997;528-535.
24. Kissinger C.R., Liu B.S., Martin-Blanco E., Kornberg T.B., Pabo C.O. Crystal structure of an engrailed homeodomain-DNA complex at 2.8 Å resolution. a framework for understanding homeodomain-DNA interactions Cell. 63:1990;579-590.
25. Klemm J.D., Rould M.A., Aurora R., Herr W., Pabo C.O. Crystal structure of the Oct-1 POU domain bound to an octamer site. DNA recognition with tethered DNA-binding modules Cell. 77:1994;21-32.
26. LaFortelle E., Bricogne G. Maximum-likelihood heavy atom parameter refinement in the MIR and MAD methods. Methods Enzymol. 276:1997;472-494.
27. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W.et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
28. Lehto M., Wipemo C., Ivarsson S.A., Lindgren C., Lipsanen-Nyman M., Weng J., Wibell L., Widen E., Tuomi T., Groop L. High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes. Diabetologia. 42:1999;1131-1137.
29. Mendel D.B., Crabtree G.R. HNF-1, a member of a novel class of dimerizing homeodomain proteins. J. Biol. Chem. 266:1991;677-680.
30. Moller A.M., Dalgaard L.T., Pociot F., Nerup J., Hansen T., Pedersen O. Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes. Diabetologia. 41:1998;1528-1531.
31. Narayana N., Hua Q., Weiss M.A. The dimerization domain of HNF-1alpha. structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus J. Mol. Biol. 310:2001;635-658.
32. Ng M.C., Cockburn B.N., Lindner T.H., Yeung V.T., Chow C.C., So W.Y., Li J.K., Lo Y.M., Lee Z.S., Cockram C.S.et al. Molecular genetics of diabetes mellitus in Chinese subjects. identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY Diabet. Med. 16:1999;956-963.
33. Nicosia A., Monaci P., Tomei L., De Francesco R., Nuzzo M., Stunnenberg H., Cortese R. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell. 61:1990;1225-1236.
34. Otting G., Qian Y.Q., Billeter M., Muller M., Affolter M., Gehring W.J., Wuthrich K. Protein-DNA contacts in the structure of a homeodomain-DNA complex determined by nuclear magnetic resonance spectroscopy in solution. EMBO J. 9:1990;3085-3092.
35. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
36. Rose R.B., Bayle J.H., Endrizzi J.A., Cronk J.D., Crabtree G.R., Alber T. Structural basis of dimerization, coactivator recognition and MODY3 mutations in HNF-1alpha. Nat. Struct. Biol. 7:2000;744-748. a.
37. Rose R.B., Endrizzi J.A., Cronk J.D., Holton J., Alber T. High-resolution structure of the HNF-1alpha dimerization domain. Biochemistry. 39:2000;15062-15070. b.
38. Sarkar G., Sommer S.S. The "megaprimer" method of site-directed mutagenesis. Biotechniques. 8:1990;404-407.
39. Schott O., Billeter M., Leiting B., Wider G., Wuthrich K. The NMR solution structure of the non-classical homeodomain from the rat liver LFB1/HNF1 transcription factor. J. Mol. Biol. 267:1997;673-683.
40. Scully K.M., Jacobson E.M., Jepsen K., Lunyak V., Viadiu H., Carriere C., Rose D.W., Hooshmand F., Aggarwal A.K., Rosenfeld M.G. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science. 290:2000;1127-1131.
41. Shih D.Q., Screenan S., Munoz K.N., Philipson L., Pontoglio M., Yaniv M., Polonsky K.S., Stoffel M. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes. 50:2001;2472-2480.
42. Tomei L., Cortese R., De Francesco R. A POU-A related region dictates DNA binding specificity of LFB1/HNF1 by orienting the two XL-homeodomains in the dimer. EMBO J. 11:1992;4119-4129.
43. Tronche F., Ringeisen F., Blumenfeld M., Yaniv M., Pontoglio M. Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome. J. Mol. Biol. 266:1997;231-245.
44. Urhammer S.A., Fridberg M., Hansen T., Rasmussen S.K., Moller A.M., Clausen J.O., Pedersen O. A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1α gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes. 46:1997;912-916.
45. Vaxillaire M., Abderrahmani A., Boutin P., Bailleul B., Froguel P., Yaniv M., Pontoglio M. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J. Biol. Chem. 274:1999;35639-35646.
46. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A.et al. The sequence of the human genome. Science. 291:2001;1304-1351.
47. Wolberger C. Homeodomain interactions. Curr. Opin. Struct. Biol. 6:1996;62-68.
48. Yamada S., Nishigori H., Onda H., Utsugi T., Yanagawa T., Maruyama T., Onigata K., Nagashima K., Nagai R., Morikawa A.et al. Identification of mutations in the hepatocyte nuclear factor (HNF)-1 alpha gene in Japanese subjects with IDDM. Diabetes. 46:1997;1643-1647.
49. Yamada S., Tomura H., Nishigori H., Sho K., Mabe H., Iwatani N., Takumi T., Kito Y., Moriya N., Muroya K.et al. Identification of mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with early-onset NIDDM and functional analysis of the mutant proteins. Diabetes. 48:1999;645-648.
50. Yamagata K., Oda N., Kaisaki P.J., Menzel S., Furuta H., Vaxillaire M., Southam L., Cox R.D., Lathrop G.M., Boriraj V.V.et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature. 384:1996;455-458.
51. Yang Q., Yamagata K., Yamamoto K., Miyagawa J., Takeda J., Iwasaki N., Iwahashi H., Yoshiuchi I., Namba M., Miyazaki J.et al. Structure/function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor. Biochem. Biophys. Res. Commun. 266:1999;196-202.
52. Yoshiuchi I., Yamagata K., Yang Q., Iwahashi H., Okita K., Yamamoto K., Oue T., Imagawa A., Hamaguchi T., Yamasaki T.et al. Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus. clinical features and functional characterization Diabetologia. 42:1999;621-626.